Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$0.53 - $1.34 $132 - $335
-250 Reduced 2.4%
10,170 $6,000
Q2 2024

Jul 19, 2024

BUY
$1.14 - $2.97 $285 - $742
250 Added 2.46%
10,420 $13,000
Q1 2024

May 02, 2024

SELL
$1.95 - $4.04 $715 - $1,482
-367 Reduced 3.48%
10,170 $28,000
Q4 2023

Feb 06, 2024

BUY
$2.32 - $5.51 $24,445 - $58,058
10,537 New
10,537 $31,000

Others Institutions Holding BTAI

About BioXcel Therapeutics, Inc.


  • Ticker BTAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,022,500
  • Market Cap $83.5M
  • Description
  • BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...
More about BTAI
Track This Portfolio

Track Apollon Wealth Management, LLC Portfolio

Follow Apollon Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Apollon Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Apollon Wealth Management, LLC with notifications on news.